Literature DB >> 23774172

Retrospective evaluation of elastic stain in the assessment of serosal invasion of pT3N0 colorectal cancers.

Wen-Yih Liang1, Wei-Chin Chang, Chih-Yi Hsu, Thomas Arnason, David Berger, Alexander T Hawkins, Patricia Sylla, Gregory Y Lauwers.   

Abstract

Peritoneal involvement is an important adverse prognostic factor in colorectal cancer (CRC) and determines a shift in the pathologic tumor node metastasis stage. Because peritoneal involvement is difficult to identify, use of special stains highlighting the peritoneal elastic lamina and mesothelial surface has been proposed. This study aims to determine whether use of elastic stain or CK7 immunohistochemistry on a single tissue section can refine the level of tumor invasion and determine whether restaging based on this assessment has prognostic significance in pT3N0 CRCs. Elastic stains were applied to 1 block per case from 244 consecutively resected pT3N0M0 CRCs. CK7 was evaluated in a 169-case subset. The elastic lamina was identified in only 101 cases (41%). Of those, 60 cases (24.6%) displayed elastic lamina invasion (ELI). This finding was associated with significantly worse (P<0.001) disease-free survival (DFS) (5-y DFS=60%) and significantly worse (P=0.01) overall survival (OS) (5-y OS=66.7%) compared with patients with no ELI (5-y DFS=87.8%, OS=92.7%) and those for whom no elastic lamina was identified (5-y DFS=82.5%, OS=86.0%). CK7 staining highlighted mesothelial cells in only 27 of 169 cases tested and helped demonstrate serosal invasion in only 5 cases (3%). In summary, the use of a single elastic stain is a useful and inexpensive method to demonstrate peritoneal involvement by tumor and should be considered for routine use in all pT3N0 CRCs. As tumors with ELI have an adverse prognosis, we propose that they should be upstaged compared with pT3N0 tumors without ELI.

Entities:  

Mesh:

Year:  2013        PMID: 23774172     DOI: 10.1097/PAS.0b013e31828ea2de

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  7 in total

Review 1.  Controversies in the pathological assessment of colorectal cancer.

Authors:  Aoife Maguire; Kieran Sheahan
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

Review 2.  Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).

Authors:  Paolo Sammartino; Daniele Biacchi; Tommaso Cornali; Maurizio Cardi; Fabio Accarpio; Alessio Impagnatiello; Bianca Maria Sollazzo; Angelo Di Giorgio
Journal:  Indian J Surg Oncol       Date:  2016-01-26

3.  Spread of tumor microenvironment contributes to colonic obstruction through subperitoneal fibroblast activation in colon cancer.

Authors:  Mitsuru Yokota; Motohiro Kojima; Youichi Higuchi; Yuji Nishizawa; Akihiro Kobayashi; Masaaki Ito; Norio Saito; Atsushi Ochiai
Journal:  Cancer Sci       Date:  2015-03-19       Impact factor: 6.716

4.  Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis.

Authors:  Motohiro Kojima; Youichi Higuchi; Mitsuru Yokota; Genichiro Ishii; Norio Saito; Kazuhiko Aoyagi; Hiroki Sasaki; Atsushi Ochiai
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

5.  Histopathology and enhanced detection of tumor invasion of peritoneal membranes.

Authors:  Jey-Hsin Chen; Melissa Borges
Journal:  PLoS One       Date:  2017-03-10       Impact factor: 3.240

6.  Prognostic significance of additional histologic features for subclassification of pathological T3 colon cancer.

Authors:  Lorenzo Macchi; Quoc Riccardo Bao; Laura Albertoni; Matteo Fassan; Valentina Chiminazzo; Marco Scarpa; Gaya Spolverato; Salvatore Pucciarelli
Journal:  Int J Clin Oncol       Date:  2022-06-18       Impact factor: 3.850

7.  The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer.

Authors:  Jun Lu; Xiumei Hu; Yutong Meng; Hongying Zhao; Qing Cao; Mulan Jin
Journal:  PLoS One       Date:  2018-04-09       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.